A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of ONO-2333Ms in patients with recurrent major depressive disorder.

Trial Profile

A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of ONO-2333Ms in patients with recurrent major depressive disorder.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Jun 2012

At a glance

  • Drugs ONO 2333Ms (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Oct 2011 Actual end date changed from Apr 2008 to Jun 2008 as reported by ClinicalTrials.gov.
    • 12 Nov 2008 Updated end date and actual patient number as reported in ClinicalTrials.gov record.
    • 12 Nov 2008 Status changed from active, no longer recruiting to completed, as reported in ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top